comparemela.com

Latest Breaking News On - Bethp hecht - Page 1 : comparemela.com

Aytu BioScience Announces Close of Merger with Neos Therapeutics

Aytu BioScience Announces Close of Merger with Neos Therapeutics
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

Aytu-biopharma
Bethp-hecht
Gerald-mclaughlin
Jerry-mclaughlin
Josh-disbrow
Willkie-farr-gallagher
Ketan-mehta
Sarah-mccabe
Dickinson-college
Harvard-law-school
Audit-committee
Nasdaq

Aytu BioScience Announces Close of Merger with Neos Therapeutics

Aytu BioScience Announces Close of Merger with Neos Therapeutics
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

Aytu-biopharma
Bethp-hecht
Gerald-mclaughlin
Jerry-mclaughlin
Josh-disbrow
Willkie-farr-gallagher
Ketan-mehta
Sarah-mccabe
Dickinson-college
Harvard-law-school
Audit-committee
Nasdaq

3 Penny Stocks To Watch Today After Big News This Week

Neos Therapeutics Inc. (NASDAQ: NEOS)Penny Stocks To Watch #1: PharmaDrug Inc. When you think about biotech, the first thing that might come to mind are labs designed for developing cancer treatments or vaccines. But have you thought about how this market niche has evolved over the last few years? With the inclusion of things like “natural medicines,” we’ve seen everything from cannabis to psychedelics being explored by companies. In this case, PharmaDrug is concentrating on both. Specific to the pharmaceutical market potential of alternative medicines, the studies focusing on psychedelics primarily target mental health concerns. We’re talking about a market (central nervous system therapeutics) worth nearly $205 billion by 2028. While the “cannabis play” for PharmaDrug focuses on the German market, its advancement in R&D for psychedelics is getting much more attention. Furthermore, the company isn’t “just another mushroom stock.” Itâ�

Germany
Michigan
United-states
German
Aytu-biopharma
Patrick-heron
Corey-fishman
Bethp-hecht
Daniel-cohen
Aytu-biopharma-inc
Xeris-pharmaceuticals
Pharmadrug-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.